HomeCTNM • NASDAQ
add
Contineum Therapeutics Inc
Previous close
$15.60
Day range
$15.76 - $16.00
Year range
$13.90 - $16.06
Market cap
417.68M USD
Avg Volume
102.92K
P/E ratio
17.66
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | — |
Operating expense | 9.68M | 77.57% |
Net income | -7.77M | -3.42% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.64M | -79.56% |
Effective tax rate | 2.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 125.19M | 165.01% |
Total assets | 130.39M | 157.50% |
Total liabilities | 5.70M | -49.83% |
Total equity | 124.68M | — |
Shares outstanding | 2.35M | — |
Price to book | -0.54 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.77M | -3.42% |
Cash from operations | -10.70M | -162.55% |
Cash from investing | 9.03M | 83.65% |
Cash from financing | -321.00K | 48.64% |
Net change in cash | -2.00M | -1,027.91% |
Free cash flow | — | — |
About
Founded
2009
Website
Employees
31